Involvement of MAPK pathway in hypoxia-induced up-regulation of urokinase plasminogen activator receptor in a human prostatic cancer cell line, PC3MLN4

Experimental and Molecular Medicine

Volumn 36, Issue 1, 2004, Pages 57-64

  Lee, Kyung Hee ^a   Choi, Eun Young ^a   Hyun, Myung Soo ^a   Kim, Jae Ryong ^a  

^a Yeungnam University College of Medicine   (South Korea)

Author keywords

HGF; Hypoxia; MAPK; Metastasis; UPAR

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MONOCLONAL ANTIBODY; UROKINASE RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CELL GROWTH; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPOXIA; METASTASIS; PROGNOSIS; PROSTATE CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 1642374695     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2004.8     Document Type: Article

References (29)

1. Akrit S, Silvia M, Vyomesh P, Muriel Z, Carlos B, Enrique A. The kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen- activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1α. Cancer Res 2000;60:4873-80
2. Birchmeier C, Birchmeier W. Molecular aspects of mesenchymal-epithelial interactions. Annu Rev Cell Biol 1993;9:511-40
3. Blasi F, Vassalli D, Dano K. Urokinse-type plasmonogen activator, pro-enzyme, receptor, and inhibitors. J Cell Biol 1987;104:801-4
4. Body D. Examination of the effects of epidermal growth factor on the production of urokinase and expression of the plasminogen activator receptor in a human colon cancer cell line. Cancer Res 1989;49:2427-34
5. Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Bean JM, Prosnitz LR, Dewhirst MW. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 1996;56:941-7
6. Camiolo SM, Markus G, Evers JL. Plasmonogen activator content of neoplastic and benign human prostate tissues; fibrin augmentation of an activator activity. Int J Cancer 1981;27:191-8
7. Cantero D, Friess H, Deflorin J, Zinnermann A, Riesle E. Enhanced expression of urokinase plasminogen activator and it's receptor in pancreatic carcinoma. Br J Cancer 1997;75:388-95
8. Charles HG, Tania EF, Keith RM. Hypoxia stimulates urokinase receptor expression through a heme protein-dependent pathway. Blood 1998;91:3300-7
9. Charles HG, Jennifer F, Carolyn JF, Shannyn MG. Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. Int J Cancer 1999;80:617-23
10. Cobb MH, Goldsmith EJ. How MAP kinases are regulated. J Biol Chem 1995;14843-6
11. Cuvier C, Jang A, Hill RP. Exposure to hypoxia, glucose starvation and acidosis; effect on invasive capacity of murine tumor cells and correlation with cathepsin (L+ B) secretion. Clin Exp Metastasis 1997;15:19-25
12. Dano K, Andreasen PA, Grondahl-Hansen JJ, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 1985;44:139-266
13. Darren ER, Edurne B, Emmanuel G, Daniele R, Jacques P. p42/p44 Mitogen-activated Protein Kinases Phosphorylate Hypoxia-inducible Factor 1 (HIF-1) and Enhance the Transcriptional Activity of HIF-1. J Biol Chem 1999;274:32631-7
14. Das M, Bouchey DM, Moore MJ, Hopkins DC, Nemenoff RA, Stenmark KR. Hypoxia-induced proliferative response of vascular adventitial fibroblasts is dependent on g protein- mediated activation of mitogen-activated protein kinases. J Biol Chem 2001;276:15631-40
15. De bruin PAF, Griffioen G, Verspaget HW, Vereijen JH, Dooijewaard G, van den Ingh HF, Lamers CB. Plasminogen activator profiles in neoplastic tissues of the human colon. Cancer Res 1988;48:4520-4
16. Graham CH, Hawley TS, Hawley RG, MacDougall JR. Establishment and characterizaton of first trimester human trophoblast cells with extended lifespan. Exp Cell Res 1993;204:206-12
17. Graham CH, Fitzpatrick TE, McCrae KR. Hypoxia stimulates urokinase receptor expression through a heme protein-dependent pathway. Blood 1998;3300-7
18. Kim KS, Hong YK, Lee Y, Shin JY, Chang SI, Chung SI, Joe YA. Differential inhibition of endothelial cell proliferation and migration by urokinase subdomains amino-terminal fragment and kringle domain. Exp Mol Med 2003;35:578-85
19. Krishnamachary B, Berg-Dixon S, Kelly B, Agani F, Feldser D, Ferreira G, Iyer N, LaRusch J, Pak B, Taghavi P, Semenza GL. Regulation of colon carcinoma cell invasion by hypoxia inducible factor 1. Cancer Res 2003;63:1138-43
20. Markus G, Takita H, Camiolo S, Corasanti J. Content and characterization of plasminogen activators in human lung tumors and normal lung tissue. Cancer Res 1980;40:841-8
21. Mita D, David MB, Marla JM, Daniel CH, Raphael AN, Kurt RS. Hypoxia-induced proliferative response of vascular adventitial fibroblasts is dependent on G protein-mediated activation of mitogen-activated protein kinase. J Biol Chem 2001;276:15631-40
22. Nordsmark M, Hoyer M, Keller J, Nielsen OS, Jensen OM, Overgaard J. The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas. Int J Radiat Oncol Biol Phys 1996;35:701-9
23. Ossowsky L. In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface bound urokinase. J Cell Biol 1988;107:2437-45
24. Ossowski L, Clunie G, Masucci MT, Blasi F. In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion. J Cell Biol 1991;115:1107-12
25. Sappino A, Busso N, Belin D, Vassalli J. Increase of urokinase-type plasminogen activator gene expression in human lung and breast carcinoma. Cancer Res 1987;47:4043-6
26. Seko Y, Tobe K, Ueki K, Kadowaki T, Tazaki Y. Hypoxia and hypoxia/reoxygenation activate Src family tyrosine kinases and p21ras in cultured rat cardiac myocytes. Circ Res 1996;78:82-90
27. Seko Y, Takahashi N, Tobe K, Kadowaki T, Yazaki Y. Hypoxia and hypoxia/reoxygenation activate p65PAK, p38 mitogen-activated protein kinase (MAPK), and stress-activated protein kinase (SAPK) in cultured rat cardiac myocytes. Biochem Biophys Res Commun 1997;239:840-4
28. Shuang H, Liguo N, Zhixing P, Jiahuai H, Glen R. Urokinase plasminogen activator/urokinase surface receptor expression and matrix invasion by breast cancer cells requires constitytive p38 mitogen-activated protein kinase activity. J Biol Chem 2000;275:12266-72
29. Young SD, Marshall RS, Hill PR. Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Nat Acad Sci USA 1988;85:9533-7